Ascend Wellness Launches New Edibles Brand ‘Effin’
:Targeting Specific Effects with Unique Formulations
Ascend Wellness Holdings (AAWH), a vertically integrated cannabis operator, is making waves in the edibles market with the launch of its new brand, ‘Effin’. This isn’t just another line of gummies; ‘Effin’ is designed to deliver specific effects through expertly formulated combinations of THC and minor cannabinoids like THCV, CBN, CBG, and CBD.
The company, based in New Jersey, believes consumers are looking for more than just a basic edible experience. They want products tailored to their specific needs, whether it’s relaxation, sleep, focus, or energy. ‘Effin’ is designed to answer that call.
The brand made its initial debut in Massachusetts and Illinois in early October, and is set to launch in New Jersey by the end of the month. The four initial SKUs include:
*
Effin’ Chillin’:
This blend offers 10 mg THC to 10 mg CBD for a balanced and calming experience.*
Effin’ Sleep:
Featuring 10 mg THC and 5 mg CBN, this product is designed to promote restful sleep.*
Effin’ Hang:
This SKU packs 20 mg CBG and 10 mg THC, aiming to provide a focused and energized state.*
Effin’ Do It:
Containing 10 mg THC and 10 mg THCV, this product is designed to support motivation and energy levels.“We went mad scientist to create these unique formulations because we know our customers want more than just edibles—they want products that deliver specific effects tailored to their needs,” said David Gacom, chief commercial officer at AWH.
Ascend is scheduled to hold a conference call on Tuesday, November 12, 2024, at 8:30 am ET, following the release of its third-quarter 2024 financial results. The New York-headquartered company closed its previously announced private placement of $235 million of 12.75% senior secured notes due 2029 in July, with plans to prepay $215 million of principal amounts outstanding under its existing term loan.
AAWH Price Action
Ascend’s shares traded 3.21% higher at $0.7947 per share at the time of writing on Thursday. The company’s focus on innovation and targeted product development appears to be resonating with investors.
The launch of ‘Effin’ represents a significant step for Ascend Wellness Holdings as they continue to expand their presence in the cannabis industry and cater to the evolving needs of consumers. With their commitment to unique formulations and specific effects, ‘Effin’ could become a major player in the growing edibles market.
